This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Eosinophilia
D3_EOSINOPHILIA
Hypereosinophilic syndrome: The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
672 |
4. Check minimum number of eventsNone |
672 |
5. Include endpointsNone |
672 |
6. Filter based on genotype QC (FinnGen only) |
590 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D72
- Name in latin
- Eosinophilia
Similar endpoints
↥List of similar endpoints to
Eosinophilia
based on the number of shared cases.
Similar with more cases:
- Eosinophilic disease (BM)
- Other disorders of white blood cells
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Excluding asthma or asthma-COPD overlap
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 590 | 316 | 274 |
| Unadjusted period prevalence (%) | 0.12 | 0.11 | 0.13 |
| Median age at first event (years) | 57.17 | 53.26 | 61.68 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 614
- Matched controls
- 6140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D72.1
ICD-10 Finland
Eosinophilia
+∞
307.7
598
*
XW000
NOMESCO Finland
Bone marrow biopsy
13.5
108.4
110
98
J32.4
ICD-10 Finland
Chronic pansinusitis
24.6
96.3
70
32
J45.1
ICD-10 Finland
Nonallergic asthma
7.9
91.3
144
228
J45.9
ICD-10 Finland
Asthma, unspecified
5.3
86.3
254
725
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
35.4
81.5
52
16
R03AK08
ATC
formoterol and beclometasone; inhalant
10.3
79.1
95
107
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.9
78.9
108
144
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.9
77.2
247
745
H02AB06
ATC
prednisolone; systemic
4.8
71.1
445
2175
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.0
68.7
142
292
J33.0
ICD-10 Finland
Polyp of nasal cavity
11.2
66.8
74
74
R03DC03
ATC
montelukast; oral
4.7
66.2
207
604
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
11.0
63.4
71
72
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
11.3
61.0
67
66
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
6.9
55.0
92
152
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.0
54.1
107
209
R03BB04
ATC
tiotropium bromide; inhalant
5.0
53.3
133
319
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
5.5
52.1
114
244
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
51.2
419
2257
J45
ICD-10 Finland
Asthma
4.7
46.5
127
326
XG474
NOMESCO Finland
Exhalation nntrogen oxide
8.8
46.4
61
76
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
6.3
44.5
81
145
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
161.5
43.4
45
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.0
41.4
100
231
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
225.0
41.4
42
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
40.6
292
1399
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.1
39.1
62
96
J46
ICD-10 Finland
Status asthmaticus
8.9
37.3
48
58
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
37.1
148
494
DHB20
NOMESCO Finland
Polypectomy of internal nose
11.8
36.6
38
34
R03BA08
ATC
ciclesonide; inhalant
4.3
36.2
104
275
J33.8
ICD-10 Finland
Other polyp of sinus
9.0
36.0
46
55
R01AD08
ATC
fluticasone; nasal
2.9
35.3
247
1147
XQ800
NOMESCO Finland
Prick test
4.6
34.0
88
214
J45.8
ICD-10 Finland
Mixed asthma
7.7
34.0
49
68
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.4
33.4
150
537
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.2
32.3
50
75
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.2
31.9
93
248
R03BA05
ATC
fluticasone; inhalant
3.1
31.4
170
678
R03AC02
ATC
salbutamol; inhalant
2.8
31.3
420
2670
H02AB07
ATC
prednisone; oral
3.4
31.2
134
465
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
30.5
106
320
H02AB09
ATC
hydrocortisone; systemic
7.6
30.0
44
62
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
29.1
110
351
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.7
27.3
53
100
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
26.9
223
1101
H02AB04
ATC
methylprednisolone; systemic
3.1
26.9
138
530
WZC30
NOMESCO Finland
Teaching
2.9
26.7
155
637
R50.9
ICD-10 Finland
Fever, unspecified
3.0
26.7
146
581
ZX112
NOMESCO Finland
Subcutaneous
7.0
24.9
39
59
R06AE07
ATC
cetirizine; oral
2.4
24.9
318
1898
R03AK11
ATC
formoterol and fluticasone; inhalant
6.7
24.6
40
63
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
24.5
231
1202
R96
ICPC
Asthma
3.4
24.4
99
329
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.5
24.2
49
96
ZXE00
NOMESCO Finland
One hour or less
2.4
24.2
290
1678
TGC00
NOMESCO Finland
Bronchial lavation
5.7
23.4
45
84
R03AK07
ATC
formoterol and budesonide; inhalant
2.6
22.2
173
818
3028
Kela drug reimbursment
Mepolizumab
227.8
21.7
22
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
21.0
79
249
R03AC12
ATC
salmeterol; inhalant
4.5
20.9
54
130
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
20.9
104
389
R03DX09
ATC
mepolizumab; parenteral
217.1
20.7
21
*
R01AD09
ATC
mometasone; nasal
2.2
20.3
326
2083
J01MA12
ATC
levofloxacin; systemic
2.5
20.2
151
697
M05BA04
ATC
alendronic acid; oral
3.4
20.1
78
251
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
17.1
19.8
31
19
R01AD12
ATC
fluticasone furoate; nasal
2.3
19.8
230
1288
297, ,
Kela drug reimbursment
206.4
19.7
20
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.5
19.4
70
215
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.4
19.3
165
808
R03AC13
ATC
formoterol; inhalant
4.1
19.2
56
148
R05
ICD-10 Finland
Cough
2.4
18.8
167
831
R06AE09
ATC
levocetirizine; oral
2.7
18.8
117
492
J01MA14
ATC
moxifloxacin; systemic
3.1
18.7
87
312
R03DC01
ATC
zafirlukast; oral
7.7
18.4
26
35
A02BC02
ATC
pantoprazole; systemic
2.3
18.1
455
3404
R03BA01
ATC
beclometasone; inhalant
2.7
18.0
115
489
2883X
ICD-9 Finland
Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]
+∞
17.8
17
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
17.5
365
2525
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
17.4
90
342
J01AA02
ATC
doxycycline; systemic
2.4
17.3
496
3882
R03BA02
ATC
budesonide; inhalant
2.4
16.8
145
708
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
174.5
16.6
17
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
16.4
83
312
DPA30
NOMESCO Finland
Sphenotomy
15.9
16.3
26
17
A02BC01
ATC
omeprazole; systemic
2.1
16.2
199
1122
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
16.2
186
1022
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.5
16.0
57
173
UJF30
NOMESCO Finland
Ileoscopy through colon
2.8
15.9
88
347
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.2
15.8
181
993
R03DA04
ATC
theophylline; systemic, rectal
3.8
15.6
50
141
L04AX01
ATC
azathioprine; systemic
4.0
15.3
44
115
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
15.2
249
1554
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
24.1
15.2
21
9
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.7
15.2
50
144
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.2
15.1
63
211
L29.9
ICD-10 Finland
Pruritus, unspecified
4.9
15.1
34
73
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
58.2
14.8
17
*
WX002
NOMESCO Finland
Sedation and analgesia
2.2
14.8
145
744
J33.9
ICD-10 Finland
Nasal polyp, unspecified
11.8
14.4
26
23
R01AD05
ATC
budesonide; nasal
3.1
14.3
64
224
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
14.2
144
748
XG410
NOMESCO Finland
Flow-volume spirometry
4.0
14.2
42
112
R03AC03
ATC
terbutaline; inhalant
2.5
14.2
104
470
D07AD01
ATC
clobetasol; topical
2.3
14.2
124
606
JN4BD
NOMESCO Finland
Extensive body CT
2.6
13.8
84
347
L04AX03
ATC
methotrexate; systemic
2.7
13.7
82
336
E0000UV, ,
ATC
1.9
13.6
282
1888
D11AH05
ATC
dupilumab; topical
76.9
13.6
15
*
R06.0
ICD-10 Finland
Dyspnoea
2.0
13.6
197
1169
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
4.1
13.1
36
91
R06.2
ICD-10 Finland
Wheezing
3.5
12.8
46
140
C03CA01
ATC
furosemide; systemic
2.0
12.8
198
1198
395
Kela drug reimbursment
Dupilumab
71.4
12.6
14
*
L04AA06
ATC
mycophenolic acid; systemic
5.3
12.3
25
49
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.1
12.2
53
182
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
12.1
142
776
J01FF01
ATC
clindamycin; systemic
1.9
12.1
186
1119
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.8
12.0
61
229
J01FA09
ATC
clarithromycin; systemic
1.9
11.8
206
1291
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
11.7
158
909
R06AX13
ATC
loratadine; oral
2.2
11.6
105
518
J31.0
ICD-10 Finland
Chronic rhinitis
2.6
11.4
71
296
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
9.9
11.3
22
23
WW200
NOMESCO Finland
Immunization
4.7
11.3
26
57
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
11.2
123
655
J01FA06
ATC
roxithromycin; oral
1.8
11.2
255
1732
T78.4
ICD-10 Finland
Allergy, unspecified
3.5
11.1
39
117
UJF32
NOMESCO Finland
Coloscopy
1.9
11.1
176
1067
N18.8
ICD-10 Finland
Other chronic renal failure
5.0
11.0
24
50
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
21.9
10.7
15
7
R06AX27
ATC
desloratadine; oral
1.9
10.7
191
1201
J01DB01
ATC
cefalexin; oral
2.1
10.5
518
4407
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
10.5
199
1272
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.6
10.4
35
102
ZXA10
NOMESCO Finland
Bilateral
2.0
10.3
129
718
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
10.3
82
382
318
Kela drug reimbursment
Teriparatide
23.8
10.3
14
6
H05AA02
ATC
teriparatide; parenteral
23.8
10.3
14
6
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
10.2
232
1563
D07AC01
ATC
betamethasone; topical
1.8
10.2
235
1591
J47
ICD-10 Finland
Bronchiectasis
4.7
10.1
23
50
R01AD58
ATC
fluticasone, combinations; nasal
1.9
10.0
167
1024
3027
Kela drug reimbursment
Benralizumab
40.8
10.0
12
*
R03DX10
ATC
benralizumab; systemic
40.8
10.0
12
*
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
4.3
10.0
26
63
D07AC13
ATC
mometasone; topical
1.8
9.9
181
1140
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
9.8
124
693
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
9.7
65
280
UDM02
NOMESCO Finland
Sinoscopy
4.0
9.7
27
69
R06AX22
ATC
ebastine; oral
2.0
9.6
115
629
R53
ICD-10 Finland
Malaise and fatigue
1.8
9.6
173
1084
R01AD01
ATC
beclometasone; nasal
2.1
9.6
105
556
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
9.5
78
369
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.3
9.4
78
370
I42.3
ICD-10 Finland
Endomyocardial (eosinophilic) disease
+∞
9.4
9
*
R02
ICPC
Shortness of breath/dyspnoea
2.1
9.4
98
510
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.8
9.4
21
45
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
9.3
45
164
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.7
9.3
30
85
N02AX02
ATC
tramadol; systemic, rectal
1.7
9.1
271
1955
J01FA10
ATC
azithromycin; systemic
1.7
9.0
354
2745
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.9
8.9
26
69
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
8.7
82
409
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
8.7
67
308
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.1
8.7
24
61
A07AA02
ATC
nystatin; oral
2.8
8.6
43
160
R20.2
ICD-10 Finland
Paraesthesia of skin
2.5
8.6
54
226
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.3
8.5
22
53
XG405
NOMESCO Finland
Education on PEF monitoring
7.5
8.5
19
26
B01AA03
ATC
warfarin; systemic
1.9
8.5
113
641
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
8.4
311
2355
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.6
8.4
20
45
SPAT1254
SPAT
Administration of medicine
2.0
8.4
98
530
Z3231
NOMESCO Finland
Registered nurse
1.7
8.3
173
1125
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.3
8.3
66
307
J01CA04
ATC
amoxicillin; systemic
1.9
8.3
505
4362
B03XA02
ATC
darbepoetin alfa; parenteral
4.3
8.3
21
50
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.2
132
794
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
14.7
8.2
13
9
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
8.2
144
892
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
8.1
47
189
251, ,
Kela drug reimbursment
33.8
8.1
10
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.5
8.0
53
227
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.4
8.0
20
47
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
7.9
31
100
XX3DW
NOMESCO Finland
Time consuming IT work
2.1
7.9
76
382
A46
ICD-10 Finland
Erysipelas
2.0
7.9
96
527
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.9
163
1057
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.1
7.9
21
52
L04AA01
ATC
[U] ciclosporin
9.6
7.8
15
16
A02BC05
ATC
esomeprazole; systemic
1.6
7.8
248
1799
UDC00
NOMESCO Finland
Ear microscopy
2.4
7.8
56
250
D07AB08
ATC
desonide; topical
2.1
7.7
77
393
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.0
7.7
33
113
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
7.6
181
1217
M05BX04
ATC
denosumab; parenteral
2.7
7.6
42
165
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.6
7.6
43
171
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
7.5
99
559
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.6
7.5
18
28
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.9
7.4
34
121
S97
ICPC
Chronic ulcer skin
2.4
7.4
52
230
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
7.3
28
89
A03
ICPC
Fever
1.8
7.3
114
678
D02AE01
ATC
carbamide; topical
2.5
7.3
46
193
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
7.2
65
319
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.7
7.2
37
140
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
6.7
7.2
17
26
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
7.1
257
1913
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
7.1
7.0
16
23
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
7.7
6.9
15
20
L50.0
ICD-10 Finland
Allergic urticaria
3.6
6.9
22
62
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.3
6.9
26
82
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
6.9
41
167
C07AB07
ATC
bisoprolol; oral
1.6
6.9
291
2241
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.2
6.9
18
44
R01AD11
ATC
triamcinolone; nasal
2.2
6.8
56
264
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
6.2
6.8
17
28
L50.9
ICD-10 Finland
Urticaria, unspecified
2.9
6.8
31
110
TQW80
NOMESCO Finland
Local dermatologic skincare
3.6
6.8
22
63
TK800
NOMESCO Finland
Hemodialysis
4.0
6.8
19
49
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
6.7
117
720
UJF92
NOMESCO Finland
Capsular endoscopy
4.1
6.7
18
45
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
6.6
123
769
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
6.6
28
95
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
6.6
266
2022
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
6.5
68
353
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
7.5
6.4
14
19
B44.8
ICD-10 Finland
Other forms of aspergillosis
70.6
6.4
7
*
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.4
181
1264
Z2221
NOMESCO Finland
Medical doctor
1.6
6.4
162
1101
127
Kela drug reimbursment
Transplant complication
5.3
6.4
18
35
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.5
6.3
21
61
E000001, ,
ATC
1.7
6.3
118
739
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
11.2
6.3
11
10
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
9.4
6.3
12
13
DHA10
NOMESCO Finland
Biopsy of cavity of nose
7.1
6.2
14
20
D70.89
ICD-10 Finland
Neutropenic splenomegaly
27.0
6.2
8
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
6.2
140
922
L28.1
ICD-10 Finland
Prurigo nodularis
7.8
6.1
13
17
D02AX
ATC
Other emollients and protectives
3.1
6.1
25
83
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.1
229
1703
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.2
6.1
16
39
SPAT1281
SPAT
Other administrative function
2.2
6.1
53
256
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.0
6.1
26
89
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.0
6.1
26
89
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.9
6.0
17
44
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
284
368
13.50
225.87
3.0
1.2
574.08
270.96
u/ml
1.43
275
346
202
246
11.75
163.90
1.9
1.5
2.16
16.62
iu/ml
—
5
6
154
189
10.54
122.21
2.3
1.6
—
—
—
0
0
108
97
13.30
105.82
2.1
1.7
1.50
0.78
g/l
2.15
83
80
122
144
10.33
98.81
1.7
2.4
12.20
12.37
mg/l
0.06
113
136
207
463
6.24
93.69
3.5
2.5
10.59
10.63
g/l
0.04
191
426
147
233
7.98
93.24
1.6
2.2
41.80
38.98
u/l
0.65
137
211
100
103
11.40
89.05
1.6
1.3
190.00
202.50
titre
—
12
8
69
41
18.83
84.49
1.9
1.2
4.75
1.78
u/ml
0.54
36
25
174
380
5.99
79.72
1.8
1.7
1.08
1.39
g/l
1.48
162
355
226
622
5.17
79.42
4.9
4.4
252.31
242.28
u/l
0.27
218
594
512
2911
5.57
63.78
17.4
6.8
0.53
0.19
e9/l
28.02
486
2558
194
554
4.66
63.54
3.1
2.1
321.21
379.95
nmol/l
4.05
189
521
510
3111
4.77
52.15
17.9
9.9
4.53
4.15
e9/l
2.49
491
2729
157
489
3.97
44.24
2.7
2.7
66.27
68.72
e9/l
0.43
118
357
271
1197
3.26
44.20
1.9
1.4
2.20
2.49
g/l
2.00
202
733
148
449
4.03
43.20
2.3
3.0
65.09
66.54
g/l
1.32
135
417
103
243
4.89
41.63
1.7
2.2
4.94
6.88
iu/ml
0.44
21
59
204
829
3.19
37.28
3.7
2.6
22.05
23.02
%
0.47
188
779
409
2440
3.03
36.86
23.5
11.5
0.00
0.00
e9/l
0.54
365
2010
206
884
3.00
33.74
3.6
2.6
2.25
2.30
g/l
0.46
192
820
256
1258
2.78
32.25
3.3
2.7
4.92
5.34
e6/l
0.18
233
1148
448
2926
2.96
32.01
7.7
6.6
9.98
11.77
umol/l
4.92
437
2799
72
157
5.06
31.68
2.3
3.9
1.40
2.35
ratio
1.23
36
93
56
97
6.25
31.57
2.5
3.6
1220.00
3477.86
u/ml
—
5
7
75
173
4.80
30.86
2.5
4.3
49.18
84.37
mg/l
0.50
51
150
75
173
4.80
30.86
2.5
4.3
38.74
30.37
mg/l
0.80
51
151
37
41
9.54
30.64
1.3
1.1
—
—
—
0
0
37
41
9.54
30.64
1.3
1.1
—
—
—
0
0
146
543
3.22
30.32
5.0
3.3
—
—
—
0
0
209
956
2.80
29.85
3.7
2.6
12.09
13.03
umol/l
1.20
196
892
383
2379
2.62
28.95
7.1
5.1
34.05
35.76
g/l
6.38
360
2244
421
2751
2.69
28.42
11.3
7.8
1.21
1.21
mmol/l
0.10
338
2384
393
2491
2.60
28.15
10.2
7.2
1.21
1.21
mmol/l
0.08
370
2295
534
4012
3.54
26.69
9.5
4.4
14.27
11.92
mm/h
2.71
518
3727
545
4149
3.79
26.59
13.5
8.1
77.96
79.53
u/l
0.46
534
3936
377
2402
2.48
25.78
3.3
2.5
77.57
76.79
nmol/l
0.21
351
2163
167
731
2.76
25.43
9.3
6.6
1.08
1.05
mmol/l
0.86
158
680
311
1826
2.42
25.42
4.2
3.5
13.45
97.50
e6/l
1.61
259
1392
197
940
2.61
25.23
2.3
2.0
—
—
—
0
0
29
5
60.73
25.21
1.1
1.0
—
—
—
0
0
79
221
3.95
25.18
2.5
2.3
3.72
3.80
g/l
0.12
69
206
79
221
3.95
25.18
2.5
2.3
4.14
4.21
g/l
0.23
70
206
79
221
3.95
25.18
2.5
2.3
7.31
7.38
g/l
0.14
70
206
281
1584
2.43
25.08
3.9
3.4
0.45
0.47
e6/l
0.03
230
1155
44
76
6.16
24.80
1.7
1.6
—
—
—
0
0
117
427
3.15
24.73
4.9
3.6
1.22
1.23
mmol/l
0.15
103
367
52
106
5.27
24.60
1.7
1.8
—
—
—
0
0
75
208
3.97
24.17
2.5
2.4
3.05
3.07
g/l
0.05
66
193
193
938
2.54
23.55
4.6
3.8
0.81
0.81
mmol/l
0.38
181
892
245
1335
2.39
23.19
1.5
1.3
0.59
1.59
u/ml
1.99
71
354
78
230
3.74
23.01
1.4
1.2
0.23
3.01
u/ml
—
7
9
69
191
3.94
22.25
2.5
2.3
10.08
10.47
g/l
0.30
59
175
53
120
4.74
22.17
1.5
1.5
—
—
—
0
0
69
192
3.92
22.09
2.1
3.0
—
—
—
0
0
62
160
4.20
21.99
1.7
1.6
—
—
—
0
0
53
123
4.62
21.51
1.3
1.5
231.39
248.50
u/ml
0.16
36
68
122
491
2.85
21.48
10.3
8.5
11.35
9.81
mmol/l
1.28
116
475
333
2115
2.26
21.44
5.7
3.8
36.41
50.75
ng/l
0.38
250
1527
29
37
8.18
21.44
1.8
1.4
—
—
—
0
0
29
37
8.18
21.44
1.8
2.2
209.27
170.81
e6/l
0.51
22
32
65
177
3.99
21.43
2.5
2.4
0.00
0.03
g/l
0.50
55
163
69
197
3.82
21.28
2.6
2.6
0.57
0.90
g/l
0.37
58
177
281
1676
2.25
20.98
4.3
3.3
1951.44
1219.30
ng/l
0.71
257
1455
38
67
5.98
20.95
2.1
2.0
32.66
32.94
pg
0.15
38
67
46
98
4.99
20.66
1.4
1.1
0.73
2.10
u/ml
1.17
30
52
155
717
2.55
20.66
2.1
1.9
—
—
—
0
0
148
675
2.57
20.28
2.1
2.0
—
—
—
0
0
380
2586
2.23
20.14
16.7
14.2
1.25
1.24
inr
0.19
349
2134
26
32
8.44
19.77
1.6
1.4
—
—
—
0
0
47
107
4.67
19.51
1.7
1.4
—
—
—
0
0
41
84
5.16
19.25
1.3
1.1
1.73
1.82
u/ml
0.02
23
40
44
97
4.81
18.98
1.6
1.3
—
—
—
0
0
44
97
4.81
18.98
1.6
1.3
—
—
—
0
0
57
155
3.95
18.79
2.6
2.5
0.00
0.00
g/l
-0.00
50
149
27
37
7.59
18.79
1.9
2.1
351.55
434.79
e6/l
0.52
20
29
60
170
3.80
18.67
2.6
2.4
0.00
0.00
g/l
-0.00
50
150
59
166
3.83
18.54
1.9
1.6
—
—
—
0
0
77
261
3.23
18.20
1.6
2.0
1.61
1.50
g/l
0.43
64
232
51
133
4.09
17.79
1.6
1.4
—
—
—
0
0
62
186
3.60
17.74
1.6
1.5
0.00
0.11
iu/ml
—
9
33
24
31
8.02
17.53
2.2
2.4
971.83
779.52
u/ml
0.47
24
31
149
725
2.39
17.51
2.8
2.5
144.81
110.94
ug/g
0.42
131
579
46
113
4.32
17.35
1.6
1.5
158.92
143.45
au/ml
0.29
13
35
292
1867
2.08
17.26
3.3
3.4
2.33
2.35
mmol/l
2.89
274
1695
435
3231
2.19
17.10
7.2
5.4
6.74
6.68
mmol/l
0.20
422
3063
37
77
5.05
17.05
1.7
1.6
—
—
—
0
0
271
1692
2.08
17.02
3.4
2.2
147.28
295.20
u/l
1.73
256
1597
34
66
5.39
16.93
1.2
1.0
2.79
5.85
u/ml
0.52
16
23
122
550
2.52
16.88
2.1
2.4
0.21
0.21
g/l
0.26
114
517
36
74
5.11
16.82
1.3
1.0
3.44
2.37
u/ml
0.25
22
32
234
1388
2.11
16.82
3.4
3.0
351.60
348.30
umol/l
0.18
218
1223
47
122
4.09
16.49
1.4
1.4
—
—
—
0
0
20
5
41.30
16.42
1.4
1.2
—
—
—
0
0
57
174
3.51
15.86
1.3
1.3
6.17
2.55
u/ml
—
8
18
238
1452
2.04
15.60
3.3
2.3
2.83
2.86
mg/l
0.08
208
1259
56
174
3.44
15.16
1.3
1.3
10.17
10.34
u/ml
—
9
30
38
91
4.39
14.80
1.6
1.5
—
—
—
0
0
54
170
3.39
14.32
4.3
6.2
1.75
1.53
mg/l
0.81
49
152
24
18
13.82
14.31
1.3
1.1
—
—
—
0
0
26
47
5.73
13.94
1.0
1.0
—
—
—
0
0
26
25
10.81
13.85
1.6
1.4
—
—
—
0
0
41
110
3.92
13.75
1.6
1.5
—
—
—
0
0
221
1365
1.97
13.60
6.5
4.5
87.00
89.34
%
0.65
213
1344
50
155
3.42
13.58
1.4
1.2
—
—
—
0
0
26
27
10.00
13.33
1.6
1.4
—
—
—
0
0
182
1057
2.03
13.30
1.4
1.3
41.51
31.74
iu/ml
0.43
56
333
24
42
5.91
13.29
2.1
1.6
31.00
26.17
u/ml
—
5
6
360
2623
1.90
13.29
4.9
3.1
152.73
126.15
ug/l
1.01
339
2438
248
1624
1.88
12.58
5.4
4.0
0.00
0.01
estimate
1.15
135
560
391
2959
1.88
12.47
5.0
4.0
0.00
0.01
estimate
0.93
135
568
186
1111
1.97
12.42
1.8
1.7
99315499.14
5365239.30
pmol/l
0.46
146
932
21
17
12.74
12.19
1.3
1.1
—
—
—
0
0
25
29
8.94
12.11
1.6
2.4
—
—
—
0
0
22
21
10.82
11.84
5.3
5.0
—
—
—
0
0
28
63
4.61
11.78
1.0
1.0
—
—
—
0
0
275
1890
1.82
11.73
4.2
3.4
40.82
33.18
u/l
0.39
260
1790
47
154
3.22
11.69
1.5
1.6
—
—
—
0
0
87
396
2.39
11.58
2.1
1.6
—
—
—
0
0
382
2906
1.83
11.57
5.1
3.9
0.00
0.00
estimate
0.50
143
606
28
64
4.54
11.55
1.2
1.0
0.07
0.71
u/ml
0.76
15
19
385
2938
1.83
11.52
5.1
3.9
10.47
5.74
estimate
0.17
144
610
241
1605
1.83
11.29
4.7
3.3
0.01
0.01
estimate
0.02
129
485
44
142
3.26
11.22
1.2
1.2
52.20
42.98
u/ml
—
5
17
163
962
1.95
11.11
1.3
1.3
8.63
12.43
u/ml
0.42
59
378
258
1769
1.79
10.87
3.3
2.6
53.17
62.51
u/l
1.67
243
1650
31
82
3.93
10.61
1.2
1.4
—
—
—
0
0
52
194
2.84
10.34
1.5
1.4
—
—
—
0
0
36
108
3.48
10.29
3.1
3.4
10.76
8.63
pmol/l
0.54
36
108
22
30
7.56
9.77
1.1
1.1
—
—
—
0
0
16
13
12.60
9.40
1.0
2.2
—
—
—
0
0
489
4130
1.90
9.37
5.3
4.2
14.98
14.78
pmol/l
1.01
449
3766
193
1259
1.78
9.34
2.6
1.9
1.48
1.33
mg/l
0.27
156
974
436
3563
1.77
9.24
5.7
4.7
84.63
2233.03
e6/l
—
8
58
168
1062
1.80
8.99
6.7
4.0
431.82
392.72
ng/l
0.07
137
817
23
55
4.31
8.99
1.8
1.6
59.40
63.38
%
0.18
15
42
22
51
4.44
8.93
1.1
1.2
—
—
—
0
0
580
5252
2.88
8.92
33.1
15.9
21.78
24.20
mg/l
1.32
530
4319
24
60
4.12
8.86
1.2
1.1
—
—
—
0
0
116
658
1.94
8.70
3.8
3.3
7.07
7.85
umol/l
0.21
95
582
22
53
4.27
8.52
1.1
1.2
—
—
—
0
0
22
53
4.27
8.52
1.1
1.2
—
—
—
0
0
8
0
+∞
8.35
1.0
0.0
—
—
—
0
0
75
370
2.17
8.20
2.8
2.5
27.70
22.09
au/ml
—
7
35
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
45
179
2.63
7.93
13.4
3.5
0.38
0.35
iu/ml
0.16
30
97
139
860
1.80
7.88
5.6
2.5
30.77
29.61
s
0.81
139
837
21
52
4.15
7.86
1.1
1.2
—
—
—
0
0
44
176
2.62
7.68
1.3
1.2
—
—
—
0
0
51
220
2.44
7.61
2.2
1.9
0.52
3.09
ug/l
1.24
46
195
19
31
6.29
7.59
1.5
1.2
—
—
—
0
0
141
885
1.77
7.59
2.0
1.7
1067.77
1198.00
nmol/l
1.05
107
679
22
58
3.90
7.58
1.1
1.1
—
—
—
0
0
291
2213
1.60
7.44
5.2
3.8
0.00
0.02
estimate
1.63
125
514
83
443
2.01
7.37
2.4
1.5
—
—
—
0
0
41
162
2.64
7.33
1.7
1.4
300.52
296.54
ug/g
0.03
23
98
24
69
3.58
7.33
1.4
1.2
—
—
—
0
0
70
355
2.10
7.13
6.5
4.6
2.13
1.72
mmol/l
0.56
55
270
65
322
2.14
7.03
2.7
3.6
4.23
4.58
pmol/l
1.78
55
286
36
136
2.75
7.02
1.4
1.9
—
—
—
0
0
261
1957
1.58
6.95
3.9
3.5
7.13
7.76
mmol/l
1.70
219
1640
78
416
2.00
6.93
5.9
4.4
111.12
83.91
ng/l
1.61
70
371
430
3634
1.61
6.68
4.2
3.4
59.66
48.03
u/l
1.35
402
3431
99
580
1.84
6.64
5.9
4.3
1.12
1.83
mmol/l
0.95
85
494
18
34
5.42
6.50
1.0
1.1
—
—
—
0
0
17
42
4.13
6.39
1.1
1.1
42.32
43.27
mg/l
0.03
12
33
307
2427
1.53
6.24
2.4
2.1
97.87
95.35
pmol/l
0.36
179
1280
19
53
3.67
6.08
1.5
1.7
—
—
—
0
0
41
179
2.38
5.99
1.4
1.3
—
—
—
0
0
217
1614
1.53
5.72
2.0
1.7
18.84
20.54
nmol/l
0.94
190
1356
98
598
1.76
5.72
6.0
4.3
5.79
5.72
kpa
0.33
90
580
575
5338
2.22
5.66
33.6
19.2
3.97
3.98
mmol/l
0.55
569
5225
550
5034
1.89
5.55
28.9
15.2
79.03
81.49
ml/min/173m2
1.69
529
4639
538
4897
1.80
5.45
6.5
5.2
1.86
1.92
mu/l
0.55
507
4503
64
348
1.94
5.39
1.9
1.7
—
—
—
0
0
87
525
1.77
5.27
2.7
2.4
29.69
126.73
u/l
0.54
77
442
154
1078
1.57
5.27
2.9
2.9
2.46
2.45
mmol/l
0.21
138
975
14
26
5.48
5.25
1.7
2.1
0.75
0.62
u/ml
—
5
8
20
65
3.15
5.11
1.5
1.9
—
—
—
0
0
102
653
1.67
4.99
9.9
9.3
1.13
1.07
mmol/l
0.05
78
538
25
94
2.73
4.97
1.3
1.3
2.22
4.47
u/ml
—
9
34
33
143
2.38
4.93
5.0
2.8
2.86
2.20
index
0.35
22
85
238
1852
1.47
4.86
5.0
4.2
13.84
10.71
mg/mmol
0.31
161
1154
143
1005
1.55
4.76
3.5
3.0
0.57
0.93
e6/l
1.94
82
544
100
661
1.61
4.31
10.4
9.2
11.05
12.08
kpa
2.00
93
642
100
661
1.61
4.31
10.3
9.2
5.07
5.12
kpa
0.23
93
640
131
923
1.53
4.28
3.6
3.2
1.92
1.99
e6/l
0.04
69
460
15
39
3.92
4.22
1.1
1.2
—
—
—
0
0
65
385
1.77
4.21
1.3
1.2
89.40
155.90
u/ml
0.96
26
146
20
74
2.76
4.12
1.6
1.8
—
—
—
0
0
18
64
2.87
3.99
1.2
1.2
—
—
—
0
0
18
64
2.87
3.99
1.2
1.1
—
—
—
0
0
18
64
2.87
3.99
3.9
3.9
—
—
—
0
0
21
82
2.62
3.92
1.6
1.3
—
—
—
0
0
21
82
2.62
3.92
1.6
1.3
—
—
—
0
0
21
83
2.58
3.83
1.6
1.3
—
—
—
0
0
21
83
2.58
3.83
1.6
1.2
—
—
—
0
0
12
28
4.35
3.83
1.5
1.6
—
—
—
0
0
12
28
4.35
3.83
1.5
1.6
—
—
—
0
0
12
28
4.35
3.83
1.5
1.6
—
—
—
0
0
12
28
4.35
3.83
1.5
1.6
—
—
—
0
0
384
3348
1.39
3.78
3.5
3.1
—
—
—
0
0
11
24
4.65
3.76
2.4
3.5
208.09
204.46
u/l
0.06
11
24
17
61
2.84
3.71
1.2
1.1
—
—
—
0
0
22
91
2.47
3.67
1.3
1.1
—
—
—
0
0
21
85
2.52
3.67
1.6
1.2
—
—
—
0
0
21
85
2.52
3.67
1.6
1.2
—
—
—
0
0
23
98
2.40
3.61
1.3
1.3
5.00
6.30
u/ml
0.20
11
44
12
30
4.06
3.61
1.3
1.1
—
—
—
0
0
12
30
4.06
3.61
1.3
1.1
—
—
—
0
0
13
35
3.77
3.61
1.3
1.1
—
—
—
0
0
13
35
3.77
3.61
1.3
1.1
—
—
—
0
0
31
151
2.11
3.58
1.4
1.3
—
—
—
0
0
580
5516
1.93
3.52
20.7
12.1
26.42
26.29
u/l
0.06
575
5359
12
31
3.93
3.50
1.2
1.0
—
—
—
0
0
29
139
2.14
3.49
1.2
1.7
473.97
447.72
mg/l
0.19
29
130
13
37
3.57
3.42
5.1
3.0
0.77
0.78
index
0.03
13
37
10
23
4.40
3.32
1.4
1.7
—
—
—
0
0
15
54
2.82
3.27
1.1
1.1
—
—
—
0
0
30
150
2.05
3.25
1.3
1.3
—
—
—
0
0
7
11
6.42
3.19
1.4
1.1
0.01
1.40
u/ml
—
7
6
15
55
2.77
3.17
1.5
1.5
—
—
—
0
0
15
55
2.77
3.17
1.5
1.5
—
—
—
0
0
15
55
2.77
3.17
1.5
1.5
—
—
—
0
0
305
2607
1.34
3.17
3.8
2.8
—
—
estimate
—
0
0
17
67
2.58
3.15
1.4
1.3
—
—
—
0
0
12
35
3.48
3.12
1.4
1.2
0.50
0.49
ratio
—
7
19
66
432
1.59
2.98
3.5
2.7
54.60
66.72
ml/min/173m2
1.94
35
186
49
298
1.70
2.94
1.6
1.4
—
—
—
0
0
75
508
1.54
2.92
4.5
3.8
4.52
4.58
kpa
0.10
69
493
17
70
2.47
2.90
1.2
1.1
93.12
95.94
%
0.14
17
65
9
22
4.14
2.89
1.4
1.7
—
—
—
0
0
9
22
4.14
2.89
1.4
1.7
—
—
—
0
0
12
38
3.20
2.86
1.3
2.3
—
—
—
0
0
12
38
3.20
2.86
1.3
2.3
—
—
—
0
0
18
77
2.38
2.84
1.2
1.1
—
—
—
0
0
36
202
1.83
2.84
2.4
1.9
—
—
—
0
0
67
449
1.55
2.75
2.5
2.4
18.09
6.77
ug/l
0.49
61
404
14
55
2.58
2.63
1.4
1.3
9320.38
33174.26
e6/l
—
8
27
9
25
3.64
2.58
1.1
1.0
—
—
—
0
0
16
68
2.39
2.57
1.3
1.3
—
—
titre
—
0
0
5
7
7.19
2.55
1.0
1.4
41.40
45.57
umol/l
—
5
7
34
196
1.78
2.48
2.6
2.3
3706.19
5891.79
u/l
—
10
78
5
8
6.29
2.37
1.6
1.1
—
—
—
0
0
8
23
3.51
2.27
1.3
1.3
—
—
—
0
0
522
4933
1.39
2.22
7.6
6.5
40.54
39.25
mmol/mol
1.98
489
4621
6
14
4.32
2.15
1.3
1.3
—
—
—
0
0
11
42
2.65
2.15
1.5
1.5
84.91
77.05
umol/l
0.60
11
42
102
781
1.37
2.11
12.2
7.5
103.75
104.18
mmol/l
0.37
102
781
16
77
2.11
1.98
10.1
6.1
13.66
10.96
mg/l
1.58
16
71
7
21
3.36
1.97
2.6
2.2
0.55
0.61
mmol/l
—
7
21
7
21
3.36
1.97
1.6
1.4
—
—
—
0
0
5
11
4.57
1.94
1.0
1.0
0.13
0.20
u/ml
—
5
11
31
189
1.67
1.91
2.1
1.7
—
—
—
0
0
7
23
3.07
1.80
1.4
1.3
—
—
—
0
0
7
23
3.07
1.80
1.1
1.0
2157.86
1475.35
miu/ml
—
7
23
255
2242
1.23
1.80
2.3
2.0
1.44
1.36
mmol/l
0.84
198
1899
124
1004
1.29
1.76
1.7
1.6
—
—
—
0
0
8
30
2.69
1.73
1.1
1.1
327.50
180.29
iu/ml
—
8
30
7
24
2.94
1.72
1.4
1.1
—
—
—
0
0
6
19
3.18
1.66
1.3
1.1
—
—
—
0
0
87
676
1.33
1.66
1.6
1.7
1.62
1.51
%
0.81
78
594
8
32
2.52
1.60
1.5
1.6
—
964639.80
—
0
5
10
44
2.29
1.56
1.2
1.3
—
—
—
0
0
586
5711
1.57
1.55
47.7
24.4
270.74
248.58
e9/l
12.01
580
5616
544
5236
1.34
1.53
6.4
5.9
2.64
2.70
mmol/l
0.93
511
4850
586
5714
1.56
1.51
47.5
24.3
4.41
4.50
e12/l
4.26
580
5604
10
45
2.24
1.47
1.0
1.1
100.70
104.44
pmol/l
—
10
45
37
254
1.49
1.44
1.5
1.5
0.23
0.36
mg/l
0.85
18
110
536
5162
1.30
1.38
5.8
5.2
4.53
4.60
mmol/l
0.97
505
4804
51
680
0.73
1.38
5.8
5.0
31.58
31.80
%
0.05
36
442
525
5044
1.28
1.37
6.0
5.2
5.97
5.95
mmol/l
0.11
490
4620
5
17
2.96
1.36
1.0
1.6
—
—
—
0
0
27
178
1.54
1.28
1.6
1.5
452.82
282.72
mu/l
1.11
22
164
21
130
1.64
1.28
2.7
2.4
286.67
126.59
ug/min
0.33
14
70
11
55
2.02
1.28
2.4
2.4
—
—
—
0
0
40
288
1.42
1.25
1.6
2.0
—
—
—
0
0
8
38
2.12
1.18
1.1
1.1
—
—
—
0
0
14
79
1.79
1.17
1.5
2.4
4.95
4.84
umol/l
—
6
61
7
31
2.27
1.10
6.3
5.1
—
42.80
u/ml
—
0
5
48
622
0.75
1.10
6.9
7.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
21
2.39
1.09
1.4
3.1
186.60
141.38
%
—
5
21
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
5
21
2.39
1.09
3.8
2.4
41.16
40.96
g/l
—
5
21
24
161
1.51
1.08
1.5
1.2
—
—
—
0
0
24
161
1.51
1.08
1.5
1.2
—
—
—
0
0
33
239
1.40
1.03
1.6
1.5
24.50
24.48
iu/l
0.00
22
202
5
23
2.18
0.98
1.0
1.2
0.32
0.28
g/l
—
5
18
22
149
1.49
0.96
1.5
1.5
19707.50
15408.89
e6/l
0.18
16
112
44
561
0.77
0.92
2.1
2.0
3.47
3.46
ratio
0.01
32
451
529
5139
1.21
0.89
5.8
5.1
1.42
1.45
mmol/l
0.77
496
4749
14
87
1.62
0.88
1.7
1.6
49.46
49.93
ug/l
0.02
14
87
74
616
1.23
0.88
2.1
1.9
—
—
—
0
0
6
30
2.01
0.87
7.3
3.4
0.33
1.07
%
—
6
30
68
562
1.24
0.86
3.4
4.4
94.98
27.07
ug/l
0.37
56
469
79
664
1.22
0.86
2.2
2.1
—
—
—
0
0
8
47
1.71
0.81
1.6
1.4
—
—
—
0
0
44
354
1.26
0.72
1.7
2.1
—
—
—
0
0
5
26
1.93
0.70
1.4
1.2
—
—
—
0
0
506
4923
1.16
0.69
4.9
4.3
1.37
1.28
mmol/l
1.99
469
4526
20
144
1.40
0.68
1.9
1.9
8.28
5.32
iu/l
—
10
53
37
294
1.28
0.68
1.1
1.1
—
—
—
0
0
22
162
1.37
0.67
1.8
1.5
—
—
—
0
0
6
37
1.63
0.55
1.3
1.6
—
—
—
0
0
21
268
0.78
0.50
1.6
2.9
27.71
50.09
u/ml
0.73
21
255
33
271
1.23
0.49
1.4
1.3
—
—
—
0
0
146
1350
1.11
0.48
4.1
2.4
—
—
—
0
0
18
137
1.32
0.47
1.3
1.3
—
—
—
0
0
22
173
1.28
0.47
1.5
1.4
9.78
9.14
u/l
0.05
17
138
16
120
1.34
0.46
1.6
1.5
—
—
—
0
0
5
31
1.62
0.43
1.4
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
32
1.57
0.42
1.6
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
8.02
—
0
5
8
60
1.34
0.40
2.3
1.3
2.35
3.18
ug/l
—
8
54
5
35
1.43
0.39
1.4
1.3
—
—
—
0
0
192
1840
1.06
0.27
5.8
5.6
8.55
2.59
ug/l
0.48
179
1667
37
415
0.88
0.27
2.0
1.8
3.56
3.47
mmol/l
0.16
26
306
13
104
1.26
0.26
1.8
1.8
—
—
—
0
0
86
806
1.08
0.24
1.6
1.5
—
—
—
0
0
17
200
0.85
0.23
1.4
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
1.20
—
0
11
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.5
—
1.29
—
0
10
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
12
145
0.82
0.21
1.7
1.4
—
—
—
0
0
27
300
0.90
0.18
5.4
3.9
50.47
49.33
%
0.10
27
293
127
1313
0.96
0.14
5.0
4.0
1.02
1.02
kg/l
0.04
96
886
113
1100
1.03
0.09
3.1
3.2
0.83
0.76
ug/l
0.31
79
728
7
67
1.05
0.08
1.3
1.3
—
—
—
0
0
8
75
1.07
0.07
1.6
1.5
—
—
—
0
0
17
179
0.95
0.03
1.1
1.1
1.44
1.55
g/l
0.85
17
179
52
509
1.02
0.03
2.4
2.4
11.88
13.14
nmol/l
0.57
44
459
146
1474
0.99
0.03
4.3
4.7
21.94
21.60
%
0.11
75
721
14
148
0.94
0.02
2.4
2.0
191.93
227.55
pmol/l
0.52
14
137
24
233
1.03
0.01
2.3
3.2
55.50
1556.79
u/ml
1.27
18
202
19
186
1.02
0.00
1.1
1.2
0.86
0.92
g/l
0.61
19
186
12
117
1.03
0.00
2.9
4.0
24.60
28.66
mg/l
—
5
79
12
118
1.02
0.00
2.0
1.6
—
—
—
0
0
10
101
0.99
0.00
1.9
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
92.00
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
60.57
—
0
7
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.80
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
11.60
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: D3_EOSINOPHILIA – Eosinophilia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).